Frontlight ResearchEarly access
Trial site
Azienda Socio Sanitaria Locale N 2 Della Gallura
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Lung cancer2 trials
- Chronic kidney disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed2 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Bayer1 trial
- Nuvation Bio Inc.1 trial
- Universita' Degli Studi Di Torino1 trial
Running trials
Not yet recruiting
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
Closed trials
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026